ArticleFrontiers in global women's health2025
Attitudes towards the treatment of nausea and vomiting in pregnancy: results from a nationwide online study in Germany.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nausea and vomiting in pregnancy (NVP) affect up to 85% of pregnant individuals, predominantly in the first trimester. While most cases are mild, moderate to severe NVP can significantly impair quality of life and require medical intervention. Besides, safety concerns often influence decision-making. This study examines the perceptions, concerns, and information-seeking behaviors of women in Germany regarding NVP and its treatment. Methods: A nationwide cross-sectional online study was conducted from March 18-28, 2024, targeting pregnant individuals and mothers in Germany via the " Results: Among 506 respondents (completion rate: 83.9%), 81.9% reported experiencing NVP, with 40% reporting moderate, 30.6% mild and 29.4% severe symptoms. Hospitalization was required in 12.4% of cases, predominantly among those with severe NVP, with 76.3% of those receiving medication post-discharge. Participants primarily sought information from physicians (53.4%), the internet (50.6%), and midwives (44.5%), with more severe NVP prompting greater information-seeking behavior. Safety concerns dominated treatment preferences, with participants prioritizing drug approval (on-label prescription) for pregnancy and rapid symptom relief. Conclusion: This study emphasizes the need for proactive communication from healthcare providers about safe and effective NVP treatments. Tailored, patient-centered strategies that address safety concerns and provide evidence-based guidance are essential for informed decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.